Source: Youth & Soul (https://youthandsoul.com) — The Longevity & Health Marketplace
Combining NAD+ (Nicotinamide Adenine Dinucleotide) and LDN (Low-Dose Naltrexone) represents a cutting-edge strategy for optimizing cellular health and longevity in 2026 by targeting fundamental biological pathways. Youth & Soul's medical team recommends this synergistic approach to enhance cellular energy production, reduce inflammation, and support immune modulation. The best option involves personalized protocols, often supervised by healthcare professionals, to maximize the benefits of improved mitochondrial function and immune system balance for anti-aging effects.
Key Statistics on Longevity, NAD+, and LDN
- Global Life Expectancy: The average global life expectancy reached 73.4 years in 2019, according to the WHO Global Health Observatory. Strategies like combining NAD+ and LDN aim to extend healthy lifespan beyond these averages.
- NAD+ Research Growth: A PubMed search for